Selected research
Market Outlook & Growth Opportunities
Global Prescription Automation Market Outlook and Growth Opportunities 2026
Market perspective
The global Prescription Automation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Prescription Automation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Prescription Automation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prescription Automation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Prescription Automation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Prescription Automation market include McKesson, iA, BD, Omnicell, Yuyama, Baxter, TOSHO, Takazono and ScriptPro, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Prescription Automation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prescription Automation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prescription Automation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prescription Automation market.
Prescription Automation Segment by Company
McKesson
iA
BD
Omnicell
Yuyama
Baxter
TOSHO
Takazono
ScriptPro
SmartCabinet
ARxIUM
Willach
QuiqMeds
KNAPP
WellSky
Capsa Healthcare (RoboPharma)
MedAvail Technologies
NewIcon
Asteres
Prescription Automation Segment by Type
Automated Medication Dispensing
Automated Packaging and Central Fill
Automated Storage and Retrieval
Automated Medication Compounding
Others
Prescription Automation Segment by Application
Central Filling Pharmacy
Mail Order/Digital Pharmacy
Hospital Pharmacy
Retail Pharmacy
Pharmaceutical Wholesale
Prescription Automation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Prescription Automation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Prescription Automation key companies, revenue, market share, and recent developments.
3. To split the Prescription Automation breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Prescription Automation market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Prescription Automation significant trends, drivers, influence factors in global and regions.
6. To analyze Prescription Automation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Automation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription Automation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Automation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prescription Automation industry.
Chapter 3: Detailed analysis of Prescription Automation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Prescription Automation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Prescription Automation in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Medication Dispensing
- Automated Packaging and Central Fill
- Automated Storage and Retrieval
- Automated Medication Compounding
- Others
Applications
- Central Filling Pharmacy
- Mail Order/Digital Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
- Pharmaceutical Wholesale
Companies covered
- McKesson
- iA
- BD
- Omnicell
- Yuyama
- Baxter
- TOSHO
- Takazono
- ScriptPro
- SmartCabinet
- ARxIUM
- Willach
- QuiqMeds
- KNAPP
- WellSky
- Capsa Healthcare (RoboPharma)
- MedAvail Technologies
- NewIcon
- Asteres
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prescription Automation Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Prescription Automation Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Prescription Automation Market Dynamics
- 2.1 Prescription Automation Industry Trends
- 2.2 Prescription Automation Industry Drivers
- 2.3 Prescription Automation Industry Opportunities and Challenges
- 2.4 Prescription Automation Industry Restraints
3 Prescription Automation Market by Company
- 3.1 Global Prescription Automation Company Revenue Ranking in 2025
- 3.2 Global Prescription Automation Revenue by Company (2021-2026)
- 3.3 Global Prescription Automation Company Ranking (2024-2026)
- 3.4 Global Prescription Automation Company Manufacturing Base and Headquarters
- 3.5 Global Prescription Automation Company Product Type and Application
- 3.6 Global Prescription Automation Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Prescription Automation Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Prescription Automation Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Prescription Automation Market by Type
- 4.1 Prescription Automation Type Introduction
- 4.1.1 Automated Medication Dispensing
- 4.1.2 Automated Packaging and Central Fill
- 4.1.3 Automated Storage and Retrieval
- 4.1.4 Automated Medication Compounding
- 4.1.5 Others
- 4.2 Global Prescription Automation Sales Value by Type
- 4.2.1 Global Prescription Automation Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Prescription Automation Sales Value by Type (2021-2032)
- 4.2.3 Global Prescription Automation Sales Value Share by Type (2021-2032)
5 Prescription Automation Market by Application
- 5.1 Prescription Automation Application Introduction
- 5.1.1 Central Filling Pharmacy
- 5.1.2 Mail Order/Digital Pharmacy
- 5.1.3 Hospital Pharmacy
- 5.1.4 Retail Pharmacy
- 5.1.5 Pharmaceutical Wholesale
- 5.2 Global Prescription Automation Sales Value by Application
- 5.2.1 Global Prescription Automation Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Prescription Automation Sales Value by Application (2021-2032)
- 5.2.3 Global Prescription Automation Sales Value Share by Application (2021-2032)
6 Prescription Automation Regional Value Analysis
- 6.1 Global Prescription Automation Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prescription Automation Sales Value by Region (2021-2032)
- 6.2.1 Global Prescription Automation Sales Value by Region: 2021-2026
- 6.2.2 Global Prescription Automation Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prescription Automation Sales Value (2021-2032)
- 6.3.2 North America Prescription Automation Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Prescription Automation Sales Value (2021-2032)
- 6.4.2 Europe Prescription Automation Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Prescription Automation Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Prescription Automation Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Prescription Automation Sales Value (2021-2032)
- 6.6.2 South America Prescription Automation Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Prescription Automation Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Prescription Automation Sales Value Share by Country, 2025 VS 2032
7 Prescription Automation Country-level Value Analysis
- 7.1 Global Prescription Automation Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Prescription Automation Sales Value by Country (2021-2032)
- 7.2.1 Global Prescription Automation Sales Value by Country (2021-2026)
- 7.2.2 Global Prescription Automation Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.7.2 France Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.14.2 China Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.17.2 India Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Prescription Automation Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Prescription Automation Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Prescription Automation Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Prescription Automation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 McKesson
- 8.1.1 McKesson Company Information
- 8.1.2 McKesson Business Overview
- 8.1.3 McKesson Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.1.4 McKesson Prescription Automation Product Portfolio
- 8.1.5 McKesson Recent Developments
- 8.2 iA
- 8.2.1 iA Company Information
- 8.2.2 iA Business Overview
- 8.2.3 iA Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.2.4 iA Prescription Automation Product Portfolio
- 8.2.5 iA Recent Developments
- 8.3 BD
- 8.3.1 BD Company Information
- 8.3.2 BD Business Overview
- 8.3.3 BD Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.3.4 BD Prescription Automation Product Portfolio
- 8.3.5 BD Recent Developments
- 8.4 Omnicell
- 8.4.1 Omnicell Company Information
- 8.4.2 Omnicell Business Overview
- 8.4.3 Omnicell Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.4.4 Omnicell Prescription Automation Product Portfolio
- 8.4.5 Omnicell Recent Developments
- 8.5 Yuyama
- 8.5.1 Yuyama Company Information
- 8.5.2 Yuyama Business Overview
- 8.5.3 Yuyama Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.5.4 Yuyama Prescription Automation Product Portfolio
- 8.5.5 Yuyama Recent Developments
- 8.6 Baxter
- 8.6.1 Baxter Company Information
- 8.6.2 Baxter Business Overview
- 8.6.3 Baxter Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.6.4 Baxter Prescription Automation Product Portfolio
- 8.6.5 Baxter Recent Developments
- 8.7 TOSHO
- 8.7.1 TOSHO Company Information
- 8.7.2 TOSHO Business Overview
- 8.7.3 TOSHO Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.7.4 TOSHO Prescription Automation Product Portfolio
- 8.7.5 TOSHO Recent Developments
- 8.8 Takazono
- 8.8.1 Takazono Company Information
- 8.8.2 Takazono Business Overview
- 8.8.3 Takazono Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.8.4 Takazono Prescription Automation Product Portfolio
- 8.8.5 Takazono Recent Developments
- 8.9 ScriptPro
- 8.9.1 ScriptPro Company Information
- 8.9.2 ScriptPro Business Overview
- 8.9.3 ScriptPro Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.9.4 ScriptPro Prescription Automation Product Portfolio
- 8.9.5 ScriptPro Recent Developments
- 8.10 SmartCabinet
- 8.10.1 SmartCabinet Company Information
- 8.10.2 SmartCabinet Business Overview
- 8.10.3 SmartCabinet Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.10.4 SmartCabinet Prescription Automation Product Portfolio
- 8.10.5 SmartCabinet Recent Developments
- 8.11 ARxIUM
- 8.11.1 ARxIUM Company Information
- 8.11.2 ARxIUM Business Overview
- 8.11.3 ARxIUM Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.11.4 ARxIUM Prescription Automation Product Portfolio
- 8.11.5 ARxIUM Recent Developments
- 8.12 Willach
- 8.12.1 Willach Company Information
- 8.12.2 Willach Business Overview
- 8.12.3 Willach Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.12.4 Willach Prescription Automation Product Portfolio
- 8.12.5 Willach Recent Developments
- 8.13 QuiqMeds
- 8.13.1 QuiqMeds Company Information
- 8.13.2 QuiqMeds Business Overview
- 8.13.3 QuiqMeds Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.13.4 QuiqMeds Prescription Automation Product Portfolio
- 8.13.5 QuiqMeds Recent Developments
- 8.14 KNAPP
- 8.14.1 KNAPP Company Information
- 8.14.2 KNAPP Business Overview
- 8.14.3 KNAPP Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.14.4 KNAPP Prescription Automation Product Portfolio
- 8.14.5 KNAPP Recent Developments
- 8.15 WellSky
- 8.15.1 WellSky Company Information
- 8.15.2 WellSky Business Overview
- 8.15.3 WellSky Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.15.4 WellSky Prescription Automation Product Portfolio
- 8.15.5 WellSky Recent Developments
- 8.16 Capsa Healthcare (RoboPharma)
- 8.16.1 Capsa Healthcare (RoboPharma) Company Information
- 8.16.2 Capsa Healthcare (RoboPharma) Business Overview
- 8.16.3 Capsa Healthcare (RoboPharma) Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.16.4 Capsa Healthcare (RoboPharma) Prescription Automation Product Portfolio
- 8.16.5 Capsa Healthcare (RoboPharma) Recent Developments
- 8.17 MedAvail Technologies
- 8.17.1 MedAvail Technologies Company Information
- 8.17.2 MedAvail Technologies Business Overview
- 8.17.3 MedAvail Technologies Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.17.4 MedAvail Technologies Prescription Automation Product Portfolio
- 8.17.5 MedAvail Technologies Recent Developments
- 8.18 NewIcon
- 8.18.1 NewIcon Company Information
- 8.18.2 NewIcon Business Overview
- 8.18.3 NewIcon Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.18.4 NewIcon Prescription Automation Product Portfolio
- 8.18.5 NewIcon Recent Developments
- 8.19 Asteres
- 8.19.1 Asteres Company Information
- 8.19.2 Asteres Business Overview
- 8.19.3 Asteres Prescription Automation Revenue and Gross Margin (2021-2026)
- 8.19.4 Asteres Prescription Automation Product Portfolio
- 8.19.5 Asteres Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst